Ackman: Valeant has no plans to sell 'crown jewel' assets - CNBC

BOSTON (Reuters) - Billionaire hedge fund manager William Ackman told television station CNBC on Monday that embattled drug company Valeant Pharmaceuticals has no plans to sell any "crown jewel" assets and that he stuck with his bet on the company because he thought he could "fix it".